IPP Bureau
GSK introduces Haleon to the world
By IPP Bureau - February 23, 2022
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Carestream India launches digital radiology solution 'DRX Compass'
By IPP Bureau - February 23, 2022
DR devices today should do more than just provide crystal clear imaging and assist during diagnosis. Hence, the ImageView Software used in DRX Compass offers upgraded cybersecurity
Zydus receives USFDA approval for Dapagliflozin tablets
By IPP Bureau - February 23, 2022
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad
Bajaj Healthcare launches Magnesium L-Threonate in nutraceutical segment.
By IPP Bureau - February 23, 2022
It is used to control, prevent and normalize the symptoms associated with Alzheimer's disease, attention disorder, bipolar disorder, Parkinson's disease among others
ACUITE upgrades ratings of Bal Pharma
By IPP Bureau - February 23, 2022
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Dr Fabrice Egros gets an additional role at Lupin
By IPP Bureau - February 23, 2022
He will continue to lead business in LATAM and Asia regions in this new role
Complement Therapeutics raises €5 million seed financing
By IPP Bureau - February 23, 2022
Appoints Dr Rafiq Hasan as CEO
Biorchestra announces US$45 million series C fundraising
By IPP Bureau - February 23, 2022
he financing was significantly oversubscribed with high demand from both existing and new investors.
Vicore advances on new chemical entity from VP03 program
By IPP Bureau - February 23, 2022
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Agilent posts Q1 FY2022 revenue at US$ 1.67 billion
By IPP Bureau - February 23, 2022
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Moderna and Thermo Fisher Scientific to deepen mRNA collaboration
By IPP Bureau - February 23, 2022
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
WHO establishes biomanufacturing training hub in South Korea
By IPP Bureau - February 23, 2022
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Merck completes acquisition of biopharma CDMO Exelead
By IPP Bureau - February 23, 2022
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
Bayer highlights pharma business plans on Media Day
By IPP Bureau - February 23, 2022
Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
Sanofi India posts CY2021 PAT at Rs. 944.4 Cr
By IPP Bureau - February 23, 2022
The company has reported total income of Rs.3031 crores during the calendar year ended December 31, 2021.
